Harms
ADVERSE EVENTS, ADVERSE REACTIONS
The investigator will submit a summary of the progress of the trial to the accredited MREC once a year. Information will be provided on the date of inclusion of the first participant, numbers of participants included and numbers of participants that have completed the trial, serious adverse events (SAEs)/serious adverse reactions, other problems, and amendments.